83 related articles for article (PubMed ID: 26766795)
1. The comparative evaluation of apoptosis produced by leuprolide or orchiectomy on rat prostate tissue.
Cakiroglu B; Hazar AI; Eyyupoglu SE; Can Balci MB; Sinanoglu O; Tuzlali P
Arch Ital Urol Androl; 2016 Jan; 87(4):265-9. PubMed ID: 26766795
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
3. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis.
Altintas D; Kokcu A; Tosun M; Cetinkaya MB; Kandemir B
J Obstet Gynaecol Res; 2008 Dec; 34(6):1014-9. PubMed ID: 19012701
[TBL] [Abstract][Full Text] [Related]
5. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
6. Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer.
Bonzani RA; Stricker HJ; Peabody JO; Menon M
J Urol; 1998 Dec; 160(6 Pt 2):2446-9. PubMed ID: 9817400
[TBL] [Abstract][Full Text] [Related]
7. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
8. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.
Furuya Y; Lin XS; Walsh JC; Nelson WG; Isaacs JT
Endocrinology; 1995 May; 136(5):1898-906. PubMed ID: 7720636
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
[TBL] [Abstract][Full Text] [Related]
10. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
Zheng JY; Fulu MY
Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
12. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
Murakoshi M; Ikeda R; Tagawa M; Suzuki M; Takekoshi S; Watanabe K
Tokai J Exp Clin Med; 1997 Sep; 22(3):111-8. PubMed ID: 9618832
[TBL] [Abstract][Full Text] [Related]
13. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
Furuya Y; Isaacs JT
Endocrinology; 1993 Dec; 133(6):2660-6. PubMed ID: 8243289
[TBL] [Abstract][Full Text] [Related]
14. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
[TBL] [Abstract][Full Text] [Related]
15. Prostatic assessment in rats after bilateral orchidectomy and calcitonin treatment.
Al-Shahat AR; Shaikh MA; Elmansy RA; Shehzad K; Kaimkhani ZA
Endocr Regul; 2011 Jan; 45(1):29-36. PubMed ID: 21314208
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
17. GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.
Hopmans SN; Duivenvoorden WC; Werstuck GH; Klotz L; Pinthus JH
Urol Oncol; 2014 Nov; 32(8):1126-34. PubMed ID: 25242517
[TBL] [Abstract][Full Text] [Related]
18. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
19. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
Yannucci J; Manola J; Garnick MB; Bhat G; Bubley GJ
J Urol; 2006 Aug; 176(2):520-5. PubMed ID: 16813881
[TBL] [Abstract][Full Text] [Related]
20. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
